Centers for Advanced Research Research & Impact Centers for Advanced ResearchAPDA Centers for Advanced Research received $800,000 in funding in 2016.The Centers support large research programs which include: research trainees; fellowship programs; early stage discovery programs and later stage clinical translation. These Centers facilitate research which is at the forefront investigations in the causes, treatments and ultimately finding the cure(s) for Parkinson’s disease. University of Alabama at Birmingham, School of MedicineDavid G. Standaert, MD, PhD, DirectorAPDA funding supports:Inflammation in PD5,054 patient visits per yearDeep Brain Stimulation (DBS) Program24 peer-reviewed manuscripts David Geffen School of Medicine at UCLAMarie-Francoise Chesselet, MD, PhD, DirectorAPDA funding supports:Epidemiological studies in humansGenetic & molecular studies in model organismsPreclinical assessment of investigational therapiesApproximately 1,000 patient visits per year Emory University School of MedicineMahlon R. DeLong, MD, DirectorAPDA funding supports:Functional surgeryResearch traineesTwo day intensive evaluation of Parkinson’s Disease patientsApproximately 10,000 total patients seen each year Boston University School of MedicineMarie Hélène Saint-Hilaire, MD, FRCP (C), DirectorAPDA funding supports:Biomarker StudiesStudies of Non-Motor SymptomsStudies of Self-Management strategies in PDActive Clinical Trials Program3500 PD Patient visits per year – Deep Brain Stimulation Program Washington University School of MedicineJoel S. Perlmutter, MD, DirectorAPDA funding supports:Provided pilot data for six currently funded NIH RO1 grantsBiomarkers for Parkinson’s Disease & cognitive impairment occurrenceExercise, emphasizing gait and balanceMore than 4,000 Parkinson’s Disease patient visits Rutgers Robert Wood Johnson Medical SchoolLawrence I. Golbe, MD, DirectorAPDA funding supports:Neuroprotective activity of a non-caffeine component of coffeeThe role of TG2 in the pathologic aggregation of alpha-synucleinL-dopa induced dyskinesia Atypical parkinsonism, progressive supranuclear palsy999 patient visits per year University of Pittsburgh Medical CenterJ. Timothy Greenamyre, MD, PhD, DirectorAPDA funding supports:Fellowship program in movement disordersIntraoperative MRI guided DBS offeredNon-motor symptoms studyTherapeutic alpha-synuclein knockdown study1,000 patient visits per year University of Virginia Health SystemMadaline B. Harrison, MD, DirectorAPDA funding supports:MR guided focused ultrasound projectsGenetics and characterization of neuropsychiatric disorders in Parkinson’s DiseaseHeritability of motor and non-motor symptoms in PDApproximately 857 patient visits per yearShare this page:
